Three-Dimensional High-Throughput Cell Encapsulation Platform to Study Changes in Cell-Matrix Interactions
Source abstract
Abstract
In their native extracellular microenvironment, cells respond to a complex array of biochemical and mechanical cues that can vary in both time and space. High-throughput methods that allow characterization of cell-laden matrices are valuable tools to screen through many combinations of variables, ultimately helping to evolve and test hypotheses related to cell-ECM signaling. Here, we developed a platform for high-throughput encapsulation of cells in peptide-functionalized poly(ethylene glycol) hydrogels. Hydrogels were synthesized using a thiol-ene, photoclick reaction, which allowed the cell matrix environment to be modified in real time. Matrix signals were dynamically altered by in situ tethering of RGDS (0-1.5 mM), a fibronectin-derived adhesive peptide that induced more elongation than RLD or IKVAV, and/or by increasing the matrix modulus (1 to 6 kPa). This method was demonstrated with aortic valvular interstitial cells (VICs), a population of cells responsible for the pathological fibrosis and matrix remodeling that leads to aortic stenosis. VIC response to cell-matrix interactions was characterized by quantifying cell morphology and the fraction of cells exhibiting α-smooth muscle actin (αSMA) stress fibers, a hallmark of the myofibroblast phenotype. VICs elongated in response to RGDS addition, with a dramatic change in morphology within 24 h. Myofibroblast activation was also dependent on RGDS addition, with VICs exhibiting high activation (16-24%) in 1 kPa gels with RGDS. Response to RGDS was path-dependent, with the amount of time exposed to the adhesive ligand important in determining VIC morphology and activation. Although VIC aspect ratios were dependent on the amount of time spent in a stiff vs soft gel, low levels of VIC activation (≤4%) were observed in any gels cultured in higher modulus (6 kPa vs 1 kPa) microenvironments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Connective tissue disorders research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biological Engineering, ‡Department of Materials Science, and §Howard Hughes Medical Institute and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado 80303, United States
Funding
Howard Hughes Medical Institute · National Institute of General Medical Sciences · National Science Foundation
References (49)
Show source-provided references
1. 10.1177/10870571980030010210.1177/108705719800300102 ↗
2. 10.1371/journal.pone.011102910.1371/journal.pone.0111029 ↗
3. 10.1371/journal.pone.007723210.1371/journal.pone.0077232 ↗
4. 10.1089/ten.2006.12.135710.1089/ten.2006.12.1357 ↗
5. 10.1038/nbt136110.1038/nbt1361 ↗
6. 10.1124/dmd.115.06602710.1124/dmd.115.066027 ↗
7. 10.1039/b814616k10.1039/b814616k ↗
8. 10.1016/j.biomaterials.2004.11.05210.1016/j.biomaterials.2004.11.052 ↗
9. 10.1126/science.119103510.1126/science.1191035 ↗
10. 10.1371/journal.pone.001992910.1371/journal.pone.0019929 ↗
11. 10.1039/C4IB00176A10.1039/C4IB00176A ↗
12. 10.1242/jcs.07950910.1242/jcs.079509 ↗
13. 10.1021/am501860710.1021/am5018607 ↗
14. 10.1016/j.biomaterials.2006.06.03510.1016/j.biomaterials.2006.06.035 ↗
15. 10.1016/j.scr.2014.04.00410.1016/j.scr.2014.04.004 ↗
16. 10.1021/ac400161j10.1021/ac400161j ↗
17. 10.1039/c1ib00002k10.1039/c1ib00002k ↗
18. 10.1038/ncomms532410.1038/ncomms5324 ↗
19. 10.1021/acsbiomaterials.5b0019610.1021/acsbiomaterials.5b00196 ↗
20. 10.1002/adma.20150135110.1002/adma.201501351 ↗
21. 10.1002/adma.20150391810.1002/adma.201503918 ↗
22. 10.1016/j.jbiomech.2009.09.01310.1016/j.jbiomech.2009.09.013 ↗
23. 10.1016/j.cell.2010.03.01510.1016/j.cell.2010.03.015 ↗
24. 10.1038/sj.jid.570061310.1038/sj.jid.5700613 ↗
25. 10.1172/JCI2428210.1172/JCI24282 ↗
26. 10.1371/journal.pone.006966710.1371/journal.pone.0069667 ↗
27. Rabkin-Aikawa E. · J. Heart Valve Dis. · 2004 · 13 · 841
28. 10.1073/pnas.130636911010.1073/pnas.1306369110 ↗
29. 10.1016/j.yjmcc.2010.12.00510.1016/j.yjmcc.2010.12.005 ↗
30. 10.1161/01.RES.0000224114.65109.4e10.1161/01.RES.0000224114.65109.4e ↗
31. 10.1016/j.carpath.2010.10.00210.1016/j.carpath.2010.10.002 ↗
32. 10.1161/CIRCGENETICS.108.82079510.1161/CIRCGENETICS.108.820795 ↗
33. 10.1016/j.actbio.2012.05.00910.1016/j.actbio.2012.05.009 ↗
34. 10.1002/term.183610.1002/term.1836 ↗
35. 10.1016/j.biomaterials.2015.01.04710.1016/j.biomaterials.2015.01.047 ↗
36. 10.1021/ma981296k10.1021/ma981296k ↗
37. 10.1002/adma.20090180810.1002/adma.200901808 ↗
38. 10.1146/annurev.cellbio.12.1.69710.1146/annurev.cellbio.12.1.697 ↗
39. 10.1038/ki.2011.21410.1038/ki.2011.214 ↗
40. Wang A. Y. · J. Am. Soc. Nephrol. · 2001 · 12 · 192710.1681/ASN.V1291927 ↗
41. 10.1016/j.biomaterials.2015.09.03510.1016/j.biomaterials.2015.09.035 ↗
42. 10.1002/jbm.a.3266010.1002/jbm.a.32660 ↗
43. 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
44. 10.1016/j.biomaterials.2013.06.02310.1016/j.biomaterials.2013.06.023 ↗
45. 10.1039/C2SM27303A10.1039/C2SM27303A ↗
46. 10.1073/pnas.151130411210.1073/pnas.1511304112 ↗
47. 10.1161/CIRCRESAHA.110.23423710.1161/CIRCRESAHA.110.234237 ↗
48. 10.1016/j.actbio.2014.11.04210.1016/j.actbio.2014.11.042 ↗
49. 10.1002/jbm.a.3416210.1002/jbm.a.34162 ↗